INOTIV INC (NOTV) Stock Fundamental Analysis
USA - NASDAQ:NOTV - US45783Q1004 - Common Stock
1.34 USD
-0.04 (-2.9%)
Overall NOTV gets a fundamental rating of 2 out of 10. We evaluated NOTV against 58 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of NOTV have multiple concerns. While showing a medium growth rate, NOTV is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
NOTV had a negative operating cash flow in the past year.
NOTV had negative earnings in 4 of the past 5 years.
In multiple years NOTV reported negative operating cash flow during the last 5 years.
1.2 Ratios
NOTV's Return On Assets of -10.39% is in line compared to the rest of the industry. NOTV outperforms 46.55% of its industry peers.
NOTV has a worse Return On Equity (-54.92%) than 70.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.39% | ||
| ROE | -54.92% | ||
| ROIC | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 23.33%, NOTV is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NOTV has declined.
NOTV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
2. Health
2.1 Basic Checks
NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NOTV has been increased compared to 1 year ago.
NOTV has more shares outstanding than it did 5 years ago.
NOTV has a worse debt/assets ratio than last year.
2.2 Solvency
NOTV has an Altman-Z score of -0.55. This is a bad value and indicates that NOTV is not financially healthy and even has some risk of bankruptcy.
NOTV has a Altman-Z score of -0.55. This is in the lower half of the industry: NOTV underperforms 79.31% of its industry peers.
NOTV has a Debt/Equity ratio of 2.73. This is a high value indicating a heavy dependency on external financing.
NOTV has a worse Debt to Equity ratio (2.73) than 89.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.55 |
ROIC/WACCN/A
WACC8.3%
2.3 Liquidity
NOTV has a Current Ratio of 1.29. This is a normal value and indicates that NOTV is financially healthy and should not expect problems in meeting its short term obligations.
NOTV's Current ratio of 1.29 is on the low side compared to the rest of the industry. NOTV is outperformed by 81.03% of its industry peers.
A Quick Ratio of 0.96 indicates that NOTV may have some problems paying its short term obligations.
The Quick ratio of NOTV (0.96) is worse than 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
NOTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.69%, which is quite impressive.
Looking at the last year, NOTV shows a small growth in Revenue. The Revenue has grown by 0.85% in the last year.
The Revenue has been growing by 62.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%
3.2 Future
Based on estimates for the next years, NOTV will show a very strong growth in Earnings Per Share. The EPS will grow by 24.97% on average per year.
Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.23% on average per year.
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NOTV is valued a bit cheaper than 65.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.44 |
4.3 Compensation for Growth
NOTV's earnings are expected to grow with 24.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.97%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NOTV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:NOTV (10/28/2025, 4:10:04 PM)
1.34
-0.04 (-2.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners25.37%
Inst Owner Change-2.12%
Ins Owners9.67%
Ins Owner Change-0.21%
Market Cap46.03M
Revenue(TTM)505.30M
Net Income(TTM)-78964000
Analysts80
Price Target5.61 (318.66%)
Short Float %6.53%
Short Ratio5.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)2.91%
Max EPS beat(2)32.07%
EPS beat(4)3
Avg EPS beat(4)12.77%
Min EPS beat(4)-5.26%
Max EPS beat(4)32.07%
EPS beat(8)4
Avg EPS beat(8)-23.22%
EPS beat(12)7
Avg EPS beat(12)-12.32%
EPS beat(16)10
Avg EPS beat(16)95.16%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)9.34%
Revenue beat(8)2
Avg Revenue beat(8)-2.76%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)9
Avg Revenue beat(16)2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.09 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 27.44 |
EPS(TTM)-2.7
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS14.71
BVpS4.19
TBVpS-5.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.39% | ||
| ROE | -54.92% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.33% | ||
| FCFM | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
F-Score4
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 24.46 | ||
| Cap/Depr | 33.99% | ||
| Cap/Sales | 3.81% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | -0.55 |
F-Score4
WACC8.3%
ROIC/WACCN/A
Cap/Depr(3y)54.31%
Cap/Depr(5y)102.83%
Cap/Sales(3y)5.33%
Cap/Sales(5y)8.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
EBIT growth 1Y-41.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year434.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-146.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-460.32%
OCF growth 3YN/A
OCF growth 5YN/A
INOTIV INC / NOTV FAQ
Can you provide the ChartMill fundamental rating for INOTIV INC?
ChartMill assigns a fundamental rating of 2 / 10 to NOTV.
Can you provide the valuation status for INOTIV INC?
ChartMill assigns a valuation rating of 1 / 10 to INOTIV INC (NOTV). This can be considered as Overvalued.
What is the profitability of NOTV stock?
INOTIV INC (NOTV) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NOTV stock?
The Earnings per Share (EPS) of INOTIV INC (NOTV) is expected to grow by 43.04% in the next year.